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Abstract Albumin, the major serum protein, binds a wide
variety of lipophilic compounds including steroids, other
lipophilic hormones and phytochemicals that bind to hormone
receptors. Albumin has a low affinity for these lipophilic
compounds. However, due to albumin’s high concentration in
serum, albumin is a major carrier of steroids and lipophilic
hormones and regulator of their access to their receptors.
Moreover, albumin functions as a sink for phytochemicals, which
prevents their binding to hormone receptors and other cellular
proteins, protecting animals from disruptive phytochemical-
mediated endocrine effects. We propose that these properties of
albumin were important in protochordates and vertebrates about
550 to 520 million years ago, just before and during the
Cambrian. At that time, animal body sizes and exposure to
phytochemicals in food were increasing, and animals in which
albumin expression was high had a selective advantage in
surviving and reproducing in the presence of toxic phytochem-
icals. This hypothesis that albumin has essential function(s) in
mammalian endocrine physiology can be tested by comparing the
effects of phytochemicals in Nagase rats that have 1/1000 the
normal albumin concentration or in mice in which the albumin
gene is knocked out with those in normal rats and mice.
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1. Introduction
The concentration of albumin in human serum is about 45
mg/ml (0.67 mM), making albumin, by far, the major protein
in serum. Albumin’s principal functions are considered to be
regulating the osmotic pressure in blood and transporting
fatty acids and other lipophilic compounds [1,2]. Whether
albumin is essential for survival of humans and other mam-
mals has been questioned because analbuminemic humans
and rats appear to function normally [3^5]. Evidently, the
concentration of other serum proteins increases to maintain
osmotic pressure and act as carriers for fatty acids and other
lipophilic molecules. However, analbuminemic humans and
rats have 1/1000 the normal albumin levels, so they are not
truly without albumin, leaving the question of whether albu-
min is essential unresolved.
Here, I propose functions for albumin in vertebrate physi-
ology that support an essential role for albumin. Although I
focus on the physiological importance of the binding by albu-
min of steroid hormones and the protective function of albu-
min in regulating the binding of exogenous lipophilic com-
pounds from plants to hormone receptors, the model is
valid for albumin’s in£uence on the binding to receptors of
other endogenous lipophilic hormones and exogenous com-
pounds from other sources (e.g. fungi, bacteria, marine envi-
ronment, synthetic chemicals) and to other targets, such as
kinases and dehydrogenases. I propose that these functions
of albumin were important early in the evolution of verte-
brates, and that albumin has been under evolutionary pres-
sure to have low selectivity or a ‘fuzzy recognition’ for lipo-
philic compounds. This contrasts with the high selectivity of
hormone receptors for ligands, which usually is a character-
istic of an essential protein. Indeed, albumin’s low selectivity
for lipophilic molecules and albumin’s ‘commonness’ may ac-
count for the acceptance of the notion that albumin is not
essential. Studies with mice that have the albumin gene
knocked out, and thus truly lack albumin, can determine if
albumin has an essential role in mammalian physiology.
2. Steroid receptors originated about 600 to 520 million years
ago
The adrenal and sex steroids: cortisol, aldosterone, estro-
gen, testosterone, and progesterone, have a central role in
development, reproduction and homeostasis in humans and
other vertebrates [6^8]. These steroids act through nuclear
receptors, a diverse group of transcription factors that also
includes receptors for retinoids, thyroid hormone, prostaglan-
dins and fatty acids, as well as receptors without a known
ligand, the orphan receptors [7^11]. The adrenal and sex ste-
roid receptors form a clade in the nuclear receptor family
[9^12]. Escriva et al. [11] have presented compelling evidence
that nuclear receptors for adrenal and sex steroids, thyroid
hormone, retinoids and prostaglandins are a ‘recent’ innova-
tion that arose in protochordates and the earliest vertebrates;
that is prior to or during the Cambrian.
3. Hormones and a closed circulatory system
A key innovation in protochordates and vertebrates was a
closed circulatory system in which hormones are synthesized
in one organ and transported in the blood to target cells,
containing a cognate hormone receptor. Binding of the hor-
mone to its receptor regulates the transcription of genes that
evoke a characteristic physiological response. Proteins in the
blood are important in transporting hormones to target cells.
These carrier proteins include sex hormone binding globulin
(SHBG), which binds estradiol and testosterone, corticoste-
roid binding globulin (CBG), thyroxine binding globulin
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(TBG) and retinol binding protein (RBP). Neither SHBG,
CBG, TBG nor RBP is homologous to albumin. However,
TBG and CBG are distant homologs: human TBG and
CBG are 41% identical.
Our search of GenBank revealed that only the mammalian
sequences of SHBG, CBG and TBG have been determined
(data not shown). A similar search found RBP sequences in
amphibia and trout. However, albumin is found in the lamp-
rey [13], a cyclostome that arose close to the origins of verte-
brates. Cyclostomes and mammals last shared a common an-
cestor about 450 million years ago, suggesting that albumin
arose either in a protochordate or early in the origins of
vertebrates about 600 to 520 million years ago, prior to or
during the Cambrian. Thus, it is likely that an ancestral al-
bumin and RBP were present during the origins of various
ligand-activated nuclear receptors in protochordates and ver-
tebrates. At that time, we propose that albumin was the prin-
cipal carrier for steroids and regulator of access to their re-
ceptors as well as a protector of steroid receptors from
occupancy by phytochemicals.
4. Albumin can regulate access of steroids and other ligands
to nuclear receptors
Albumin binds a wide variety of hydrophobic ligands in-
cluding steroids, fatty acids, retinoids, thyroid hormone, pros-
taglandins and antibiotics [1,2] (Fig. 1). The equilibrium dis-
sociation constants (Kds) for steroids are in the 1036 M to
1034 M range. In contrast, steroids, retinoids and thyroid
hormone have Kds of 10310 M to 1039 M for their nuclear
receptors; steroids and thyroxine have Kds from 10310 to 1038
for SHBG, CBG and TBG. Retinol has a Kd of about 1036
for RBP. However, despite albumin’s low a⁄nity for steroids,
albumin’s high concentration enables it to bind most of the
estradiol and a substantial part of testosterone in male and
non-pregnant female serum in the presence of SHBG [14,15].
Similarly, the high concentration of albumin enables it to
regulate binding of steroids to nuclear receptors. For example,
serum albumin regulates the access of estradiol and its metab-
olite, estriol, to the estrogen receptor [16]. This e¡ect of albu-
min depends on its di¡erent a⁄nity for estradiol and estriol
[1,2,14,15]. Estriol has 1/3 the a⁄nity of estradiol for the
estrogen receptor. However, in the presence of albumin, the
a⁄nity of estriol is twice that of estradiol for the estrogen
receptor because estriol has a lower a⁄nity than estradiol
for albumin. Walent and Gorski [17] and Arnold et al. [18]
also found that albumin could reduce the binding of estradiol
to the estrogen receptor.
5. Albumin controls the access of phytochemicals to the
estrogen receptor
Animals accumulate various lipophilic compounds in their
blood when they consume plants. Some of these compounds
such as carotenoids and linoleic acid are important nutrients.
Other compounds may have toxic e¡ects due to binding to
either hormone receptors [19^21] or enzymes [22^26]. A class
of phytochemicals that are of special interest due to their
endocrine e¡ects are £avonoids, which have some structural
similarity to estrogens (Fig. 2). Flavonoids bind to estrogen
receptor [19^21] and to aromatases [22^25], which convert
testosterone to estradiol. Albumin reduces the binding of £a-
vonoids and other lipophilic compounds to the estrogen re-
ceptor [18,27^29]. This property of albumin would be impor-
tant in regulating the action of a protoestrogen receptor early
in the evolution of vertebrates and their protochordate ances-
tors.
The synthesis of £avonoids and other animal-toxic com-
pounds by plants is an example of coevolutionary interaction
between animals and plants [30^32], in which plants synthesize
a chemical that is toxic to animals, and then animals evolve a
defense, and then a new compound is synthesized in plants
that will retard its consumption by animals. Animals defend
against these toxic compounds by degrading the toxic phyto-
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Fig. 1. Compounds that activate nuclear receptors and bind to albumin.
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chemical, to render it inactive, or modifying it, for example by
conjugation with glucuronic acid, which renders it soluble and
suitable for excretion.
We propose that albumin has a role in the detoxi¢cation
process by retarding the binding of phytochemicals and other
xenobiotics [28,29,33] to hormone receptors, hormone carrier
proteins and enzymes, which allows the inactivation and ex-
cretion of phytochemicals to occur without disruptive endo-
crine e¡ects.
Thus, albumin has important physiological functions as a
carrier of steroids and other lipophilic compounds to their
nuclear receptors and a regulator of their access to their re-
ceptors. Also, albumin protects animals from the disruptive
e¡ects due to binding of phytochemicals and xenobiotics to
hormone receptors and enzymes. This allows enzymes to me-
tabolize these chemicals for inactivation and excretion. All of
these activities of albumin would be important in the survival
and expansion of vertebrates during and after the Cambrian.
The Cambrian period from 540 to 520 million years ago is
characterized by the ‘explosive’ appearance of a wide variety
of animal body plans that are substantially larger than ani-
mals in the preceding Vendian [34^36]. The causes of the
Cambrian explosion are not fully understood. Larger animal
body sizes are thought to depend on increased atmospheric
oxygen, which supported the metabolism necessary for growth
of larger animals [37,38]. This larger size requires an increased
consumption of plants and small animals and the need to
control the toxic e¡ects of poisons in these foods. Even
now, we ingest more toxic chemicals from plants than syn-
thetic chemicals [31]. Under this selective pressure, humans
and the intestinal bacteria have evolved enzymes that can
metabolize these phytochemicals. For example, genistein and
daidzein, two iso£avonoids that have estrogenic e¡ects, have a
half-life of about 7 h in humans [39].
6. Fuzzy recognition of chemicals by albumin: a selective
advantage in the Cambrian
Animals experiencing increased exposure to phytochemicals
in the Cambrian required one or more proteins to sequester
these chemicals and prevent deleterious physiological e¡ects.
Even a protein with low a⁄nity for lipophilic molecules can
control their free concentration if the protein concentration is
in excess to the lipophilic molecule’s concentration [40]. Such
a protein needs high aqueous solubility, stability, which can
be achieved with disul¢de bonds, and not be ‘expensive’ to
synthesize; that is, not require amino acids such as trypto-
phan, which are not common in food. Albumin has these
properties. Moreover, albumin recognizes a wide variety of
small molecules with structures consisting of rings or aliphatic
chains with di¡erent degrees of desaturation [1,2]. A conse-
quence of recognizing many molecules is a low speci¢city or
fuzzy recognition of these molecules. However, fuzzy recogni-
tion coupled with albumin’s greater than 500 WM concentra-
tion in serum means that albumin will exceed the concentra-
tion of phytochemicals in serum and prevent unwanted
binding of phytochemicals to receptors and enzymes.
It is likely that several proteins had the above attributes of
albumin prior to and during the Cambrian. Indeed, insects
have proteins in their hemolymph that bind fatty acids, ster-
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Fig. 2. Comparison of the structure of £avonoids and natural and synthetic estrogens. The phenolic group on the A ring of estradiol is impor-
tant for binding to the estrogen receptor. The synthetic estrogen, diethylstilbestrol, which lacks a B ring, has a higher a⁄nity than estradiol for
the endoplasmic reticulum (ER) [21]. Evidently, the two phenolic groups can form tight bonds with the ER. Various plant and synthetic com-
pounds also contain a phenolic group and cyclic structures or aliphatic groups that enable them bind to the ER. Among the phytochemicals, it
is the iso£avonoids, which are found in soy, that have been best studied [19^21]. However, other £avonoids also bind to the estrogen receptor
[19,20,27,29,30,32].
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ols, and other hydrophobic ligands [41]. However, none of the
insect protein sequences in the database has sequence similar-
ity to albumin.
The ‘choice’ of albumin may have been a chance mutation
that increased its expression and conferred a selective advant-
age to an animal that consumed a variety of plants. It would
also confer on albumin an osmotic function, which is impor-
tant in animal physiology. The initial chance choice of albu-
min for either or both functions in a protochordate set the
course for the future function of albumin vertebrate descend-
ants, in which albumin is a high capacity, low a⁄nity binder
of lipophilic compounds.
Nagase rats, which have about 1/1000 the normal albumin
concentration [5], can be used to investigate an essential func-
tion of albumin in the response to phytochemicals, steroids
and other lipophilic hormones and xenobiotics. Transgenic
mice in which the albumin gene is knocked out would be
even better.
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